
Ibuprofen's Hidden Benefit: Cancer Risk Reduction?
Ibuprofen, a common painkiller, is showing potential in reducing the risk of endometrial and bowel cancers by targeting inflammation that promotes tumor growth and interfering with cancer cell survival genes. While promising, experts caution against long-term use due to potential risks, emphasizing that it should complement, not replace, established cancer prevention methods.


















Discussion
Join the conversation
Be the first to comment